Targeting Sedentary Behavior in CKD A Pilot and Feasibility Randomized Controlled Trial

被引:16
|
作者
Lyden, Kate [1 ,2 ]
Boucher, Robert [3 ]
Wei, Guo [3 ,4 ]
Zhou, Na [3 ]
Christensen, Jesse [5 ]
Chertow, Glenn M. [6 ]
Greene, Tom [4 ]
Beddhu, Srinivasan [3 ,7 ]
机构
[1] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA
[2] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA
[3] Univ Utah, Sch Med, Div Nephrol & Hypertens, Suite 360,421 Wakara Way, Salt Lake City, UT 84108 USA
[4] Univ Utah, Sch Med, Div Biostat, Salt Lake City, UT USA
[5] Vet Affairs Salt Lake City Hlth Care Syst, Dept Phys Med & Rehabil, Salt Lake City, UT USA
[6] Stanford Univ, Div Nephrol, Palo Alto, CA 94304 USA
[7] Vet Affairs Salt Lake City Hlth Care Syst, Med Serv, Salt Lake City, UT USA
关键词
sedentary behavior; chronic kidney disease; behavioral intervention; CHRONIC KIDNEY-DISEASE; TELEVISION VIEWING TIME; AEROBIC EXERCISE; ACTIVITY-MONITOR; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; PHYSICAL-ACTIVITY; LIFE-STYLE; POPULATION; OBESITY;
D O I
10.2215/CJN.12300720
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives We tested the feasibility of reducing sedentary behavior common in CKD. Design, setting, participants, & measurements We carried out a Sit Less, Interact, Move More intervention in a 24-week parallel-group, randomized controlled trial in patients with stages 2-5 CKD. In the intervention group (n=54), accelerometry performed at baseline and repeated every 4 weeks was used to develop and monitor adherence to individualized plans targeting sedentary and stepping durations. The control group (n=52) was provided national physical activity recommendations; accelerometry was performed at baseline and every 8 weeks. Between-groups changes from baseline to the average follow-up values at weeks 8, 16, and 24 of the sedentary and stepping durations were the coprimary end points. Results The mean age was 69 +/- 13 years. Fourteen percent were on dialysis or received a kidney transplant. Eight percent of the control group and 17% of the intervention group were lost to follow-up. Sedentary and stepping durations did not change in the control group. Within the intervention group, the maximum decrease in sedentary duration (-43; 95% confidence interval, -69 to -17 min/d) and increase in stepping duration (16; 95% confidence interval, 7 to 24 min/d) and the number of steps per day (1265; 95% confidence interval, 518 to 2012) were seen at week 20. These attenuated at week 24. In mixed effects models, overall treatment effects between groups on sedentary (-17; 95% confidence interval, -43 to 8 min/d) and stepping (6; 95% confidence interval, -3 to 15 min/d) durations and the number of steps per day, a secondary end point (652; 95% confidence interval, -146 to 1449), were not significantly different. The intervention significantly reduced secondary end points of bodymass index (-1.1; 95% confidence interval, -1.9 to -0.3 kg/m(2)) and body fat percentage (-2.1%; 95% confidence interval, -4.4% to -0.2%). Conclusions It is feasible to reduce sedentary duration and increase stepping duration in patients with CKD, but these were not sustained.
引用
收藏
页码:717 / 726
页数:10
相关论文
共 50 条
  • [41] Recruitment Strategies for Cluster Randomized Controlled Trials Targeting Workplace Sedentary Behavior- a Retrospective Review
    Mullane, Sarah L.
    Rydell, Sarah A.
    Larouche, Miranda L.
    Toledo, Meynard John L.
    Feltes, Linda H.
    Vuong, Brenna
    Crespo, Noe C.
    Pereira, Mark A.
    Buman, Matthew P.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 710 - 710
  • [42] Wearable Technology To Reduce Sedentary Behavior And CVD Risk In Older Adults: A Pilot Randomized Clinical Trial
    Roberts, Lisa M.
    Jaeger, Byron C.
    Baptista, Liliana C.
    Harper, Sara A.
    Gardner, Anna K.
    Jackson, Elizabeth A.
    Pekmezi, Dorothy
    Sandesara, Bhanuprasad
    Manini, Todd M.
    Anton, Stephen D.
    Buford, Thomas W.
    CLINICAL INTERVENTIONS IN AGING, 2019, 14 : 1817 - 1828
  • [43] Framing physical activity as a distinct and uniquely valuable behavior independent of weight management: A pilot randomized controlled trial for overweight and obese sedentary persons
    Mascola, A. J.
    Yiaslas, T. A.
    Meir, R. L.
    McGee, S. M.
    Downing, N. L.
    Beaver, K. M.
    Crane, L. B.
    Agras, S.
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2009, 14 (2-3) : E148 - E152
  • [44] Framing physical activity as a distinct and uniquely valuable behavior independent of weight management: A pilot randomized controlled trial for overweight and obese sedentary persons
    A. J. Mascola
    T. A. Yiaslas
    R. L. Meir
    S. M. McGee
    N. L. Downing
    K. M. Beaver
    L. B. Crane
    S. Agras
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2009, 14 : e148 - e152
  • [45] Behavior-Change Intervention Targeting Physical Function, Walking, and Disability After Dysvascular Amputation: A Randomized Controlled Pilot Trial
    Christiansen, Cory L.
    Miller, Matthew J.
    Murray, Amanda M.
    Stephenson, Ryan O.
    Stevens-Lapsley, Jennifer E.
    Hiatt, William R.
    Schenkman, Margaret L.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2018, 99 (11): : 2160 - 2167
  • [46] Physical activity, sedentary behavior and total wellness changes among sedentary adults: a 4-week randomized controlled trial
    Barwais, Faisal A.
    Cuddihy, Thomas F.
    Tomson, L. Michaud
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [47] Physical activity, sedentary behavior and total wellness changes among sedentary adults: a 4-week randomized controlled trial
    Faisal A Barwais
    Thomas F Cuddihy
    L Michaud Tomson
    Health and Quality of Life Outcomes, 11
  • [48] Activating Behavior to Reduce Sedentary Behavior After Stroke: A Nonrandomized Pilot Feasibility Study
    Kringle, Emily A.
    Terhorst, Lauren
    Gibbs, Bethany Barone
    Campbell, Grace
    McCue, Michael
    Skidmore, Elizabeth R.
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2020, 74 (06):
  • [49] Placebo-Controlled Feasibility Randomized Trial?
    Sanz Rubiales, Alvaro
    Luisa del Valle, Maria
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (01) : E4 - E5
  • [50] Behavioral Activation Mobile App to Motivate Smokers to Quit: Feasibility and Pilot Randomized Controlled Trial
    Borrelli, Belinda
    Bartlett, Y. Kiera
    Fulford, Daniel
    Frasco, Greg
    Armitage, Christopher J.
    Wearden, Alison
    JMIR FORMATIVE RESEARCH, 2024, 8